Neurology Overview - Concepedia

Principles

Definition

Neurology is a medical and scientific discipline dedicated to the study of the nervous system. It focuses on the diagnosis, treatment, and management of neurological disorders, encompassing research into the structure, function, and pathology of the brain, spinal cord, and peripheral nerves to advance clinical understanding and patient care.

Ontological type

Diagnostic Methods

Core Subfields

Therapeutic Approaches

Key developments

Key Figures

Functional Neuroanatomical Mapping era

Wilder Penfield [1] was a leading figure in functional neuroanatomical mapping during this era, associated with Johns Hopkins University [3] and Columbia University [4]. Penfield [1]'s key contributions included detailed cortical mapping of epileptogenic zones and functional organization, as described in EPILEPSY AND THE FUNCTIONAL ANATOMY OF THE HUMAN BRAIN [6] and THE STRUCTURAL BASIS OF TRAUMATIC EPILEPSY AND RESULTS OF RADICAL OPERATION [7], which provided reproducible functional readouts and guided surgical therapy. Smith Ely Jelliffe [2] held positions linked with Columbia University [4] and Vanderbilt University [5] during this era. Jelliffe [2] produced DISEASES OF THE NERVOUS SYSTEM [8], a comprehensive work that helped unify clinical neurology and set the stage for subsequent functional anatomical studies in this era.

Neurochemical and Molecular Pathways era

Dennis W. Choi [1] is a central figure in the Neurochemical and Molecular Pathways era, with affiliations at Stanford University [3] and Washington University in St. Louis [4]. Choi [1]'s Glutamate neurotoxicity and diseases of the nervous system [7] work helped establish excitotoxic mechanisms as drivers of neuronal injury and linked chemistry to clinical syndromes in this era. Mahlon R. DeLong [2] is a central figure linked with Johns Hopkins University [5] and the University of Chicago [6] during this era. His Alzheimer's work, including Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain [8] and Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis [9], established the cholinergic deficit as a core feature of the disease and guided mechanistic models and therapeutic directions in this era.

Proteinopathy and Biomarker Paradigm era

Clifford R. Jack [1], affiliated with the University Memory and Aging Center [3] and Harvard University [4], has been a central figure in neurology during the Proteinopathy and Biomarker Paradigm era. His key contributions include shaping the 2011 diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [7] and the 2011 Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [8], which linked biomarker and imaging findings to clinical trajectories and propelled biomarker-guided trial design. María C. Carrillo [2], affiliated with Johns Hopkins University [5] and the University of California, San Diego [6], has played a pivotal role in shaping biomarker-based frameworks during this era. Her work on the 2011 diagnosis and preclinical guidelines [7] and [8] helped integrate clinical criteria with fluid and imaging biomarkers, enabling biology-based staging and informing trial design and early intervention strategies.